207 related articles for article (PubMed ID: 22467078)
1. Primary neuroendocrine breast cancer, how much do we know so far?
Alkaied H; Harris K; Azab B; Dai Q
Med Oncol; 2012 Dec; 29(4):2613-8. PubMed ID: 22467078
[TBL] [Abstract][Full Text] [Related]
2. Case report of primary small cell neuroendocrine breast cancer.
Puscas E; Lisencu C; Neagoe I
Clujul Med; 2013; 86(2):156-9. PubMed ID: 26527939
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
[TBL] [Abstract][Full Text] [Related]
4. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
5. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.
Inno A; Bogina G; Turazza M; Bortesi L; Duranti S; Massocco A; Zamboni G; Carbognin G; Alongi F; Salgarello M; Gori S
Oncologist; 2016 Jan; 21(1):28-32. PubMed ID: 26659223
[TBL] [Abstract][Full Text] [Related]
7. Does hormonal therapy have a therapeutic role in metastatic primary small cell neuroendocrine breast carcinoma? Case report and literature review.
Alkaied H; Harris K; Brenner A; Awasum M; Varma S
Clin Breast Cancer; 2012 Jun; 12(3):226-30. PubMed ID: 22424945
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of neuroendocrine carcinoma of the breast.
Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G
Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336
[TBL] [Abstract][Full Text] [Related]
9. Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives.
Sun H; Dai S; Xu J; Liu L; Yu J; Sun T
Front Oncol; 2022; 12():848485. PubMed ID: 35692784
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
11. Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs.
Cloutier J; Thompson ED; Cimino-Mathews A; Rooper LM; Matoso A; Argani P
Hum Pathol; 2018 Dec; 82():76-86. PubMed ID: 30031098
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine tumors of the breast: Myth or reality? A systematic review].
Cheymol C; Abramovici O; Do Cao C; Dumont A; Robin YM; El Hajbi F; Dansin E; Bonneterre J; Lauridant G
Bull Cancer; 2018 Apr; 105(4):431-439. PubMed ID: 29567279
[TBL] [Abstract][Full Text] [Related]
13. Primary neuroendocrine carcinoma of the breast.
Lu CS; Huang SH; Ho CL; Chen JH; Chao TY
J BUON; 2014; 19(2):419-29. PubMed ID: 24965401
[TBL] [Abstract][Full Text] [Related]
14. Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.
Gallo M; Campione S; Di Vito V; Fortunati N; Lo Calzo F; Messina E; Ruggeri RM; Faggiano A; Colao AAL
Front Endocrinol (Lausanne); 2020; 11():610230. PubMed ID: 33584543
[TBL] [Abstract][Full Text] [Related]
15. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine breast carcinoma: a rare but challenging entity.
Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
[TBL] [Abstract][Full Text] [Related]
17. The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast.
Paone JF; Abeloff MD; Ettinger DS; Arnold EA; Baker RR
Surg Gynecol Obstet; 1981 Jan; 152(1):70-4. PubMed ID: 7455895
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
Iyoda A; Azuma Y; Sano A
Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
[TBL] [Abstract][Full Text] [Related]
19. Gestational carcinoma of the female breast.
Wallack MK; Wolf JA; Bedwinek J; Denes AE; Glasgow G; Kumar B; Meyer JS; Rigg LA; Wilson-Krechel S
Curr Probl Cancer; 1983 Mar; 7(9):1-58. PubMed ID: 6303698
[TBL] [Abstract][Full Text] [Related]
20. Rare Human Epidermal Growth Factor Receptor 2 (HER-2)-Positive Neuroendocrine Carcinoma of the Breast: A Case Report with 9-Year Follow-up.
Marijanović I; Kraljević M; Buhovac T; Karan Križanac D
Am J Case Rep; 2020 Oct; 21():e925895. PubMed ID: 33067411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
